WAYHS, C. A. .; VON DIEMEN, T. Pharmacovigilance Program impact on notifications of adverse reactions to antineoplastic drug in a university hospital. Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, [S. l.], v. 15, n. 2, p. e1118, 2024. DOI: 10.30968/rbfhss.2024.152.1118. Disponível em: https://rbfhss.org.br/sbrafh/article/view/1118. Acesso em: 22 nov. 2024.